Contents

Current Cancer Drug Targets, Volume 10 - Number 2




Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

, 10(2): 155 - 167

A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer


DOI: 10.2174/156800910791054239


Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition

, 10(2): 168 - 175

G. Zoppoli, E. Moran, D. Soncini, M. Cea, A. Garuti, I. Rocco, G. Cirmena, V. Grillo, L. Bagnasco, G. Icardi, F. Ansaldi, S. Parodi, F. Patrone, A. Ballestrero and A. Nencioni


DOI: 10.2174/156800910791054211


Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

, 10(2): 176 - 191

R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio and M. Casto


DOI: 10.2174/156800910791054130


Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors

, 10(2): 192 - 199

S. Colombo, A. Palmioli, C. Airoldi, R. Tisi, S. Fantinato, S. Olivieri, L. De Gioia, E. Martegani and F. Peri


DOI: 10.2174/156800910791054185





The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

, 10(2): 242 - 267

M. Hingorani, C. Spitzweg, G. Vassaux, K. Newbold, A. Melcher, H. Pandha, R. Vile and K. Harrington


DOI: 10.2174/156800910791054194



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science